口服抗焦虑障碍药物的临床应用分析

Clinical Application aAnalysis of Oral Anti-anxiety Disorder Drugs

广泛性焦虑障碍(generalized anxiety disorder,GAD),简称广泛性焦虑症,是神经病学和精神病学领域的常见病和多发病。GAD的发病机制复杂,涉及遗传、生化和心理等方面。由于伴有呼吸系统、神经系统、消化系统、循环系统和泌尿系统症状,大多数患者经常被误诊和漏诊,从而错过了最佳治疗时机。口服药物是治疗这种疾病的首选方法。本研究分析了GAD药物治疗进展,旨在提高临床用药的准确性。

Generalized anxiety disorder(GAD),abbreviated as generalized anxiety disorder,is a common and frequently occurring disease in the fields of neurology and psychiatry.The pathogenesis of GAD is complex,involving genetic,biochemical,and psychological aspects.Due to the presence of symptoms in the respiratory,nervous,digestive,circulatory,and urinary systems,most patients are often misdiagnosed and missed,resulting in missing the optimal treatment opportunity.Oral medication is the preferred method for treating this disease.This study analyzed the progress of GAD drug therapy with the aim of improving the accuracy of clinical medication.